Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease

Crohn's disease (CD) is a chronic relapsing and remitting inflammatory disease of the gastrointestinal tract. CD is rare in Taiwan and other Asian countries, but its prevalence and incidence have been steadily increasing. A steering committee was established by the Taiwan Society of Inflammator...

Full description

Bibliographic Details
Main Authors: Shu-Chen Wei, Ting-An Chang, Te-Hsin Chao, Jinn-Shiun Chen, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tien-Yu Huang, Tzu-Chi Hsu, Chun-Chi Lin, Hung-Hsin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chia-Tung Shun, Yuk-Ming Tsang, Cheng-Yi Wang, Horng-Yuan Wang, Meng-Tzu Weng, Deng-Chyang Wu, Wen-Chieh Wu, Hsu-Heng Yen, Jau-Min Wong
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2017-07-01
Series:Intestinal Research
Subjects:
Online Access:https://doi.org/10.5217/ir.2017.15.3.285
_version_ 1818304454285328384
author Shu-Chen Wei
Ting-An Chang
Te-Hsin Chao
Jinn-Shiun Chen
Jen-Wei Chou
Yenn-Hwei Chou
Chiao-Hsiung Chuang
Wen-Hung Hsu
Tien-Yu Huang
Tzu-Chi Hsu
Chun-Chi Lin
Hung-Hsin Lin
Jen-Kou Lin
Wei-Chen Lin
Yen-Hsuan Ni
Ming-Jium Shieh
I-Lun Shih
Chia-Tung Shun
Yuk-Ming Tsang
Cheng-Yi Wang
Horng-Yuan Wang
Meng-Tzu Weng
Deng-Chyang Wu
Wen-Chieh Wu
Hsu-Heng Yen
Jau-Min Wong
author_facet Shu-Chen Wei
Ting-An Chang
Te-Hsin Chao
Jinn-Shiun Chen
Jen-Wei Chou
Yenn-Hwei Chou
Chiao-Hsiung Chuang
Wen-Hung Hsu
Tien-Yu Huang
Tzu-Chi Hsu
Chun-Chi Lin
Hung-Hsin Lin
Jen-Kou Lin
Wei-Chen Lin
Yen-Hsuan Ni
Ming-Jium Shieh
I-Lun Shih
Chia-Tung Shun
Yuk-Ming Tsang
Cheng-Yi Wang
Horng-Yuan Wang
Meng-Tzu Weng
Deng-Chyang Wu
Wen-Chieh Wu
Hsu-Heng Yen
Jau-Min Wong
author_sort Shu-Chen Wei
collection DOAJ
description Crohn's disease (CD) is a chronic relapsing and remitting inflammatory disease of the gastrointestinal tract. CD is rare in Taiwan and other Asian countries, but its prevalence and incidence have been steadily increasing. A steering committee was established by the Taiwan Society of Inflammatory Bowel Disease to formulate statements on the diagnosis and management of CD taking into account currently available evidence and the expert opinion of the committee. Thorough clinical, endoscopic, and histological assessments are required for accurate diagnosis of CD. Computed tomography and magnetic resonance imaging are complementary to endoscopic evaluation for disease staging and detecting complications. The goals of CD management are to induce and maintain remission, reduce the risk of complications, and improve quality of life. Corticosteroids are the mainstay for inducing re-mission. Immunomodulating and biologic therapies should be used to maintain remission. Patients should be evaluated for hepatitis B virus and tuberculosis infection prior to treatment and receive regular surveillance for cancer. These consensus statements are based on current local evidence with consideration of factors, and could be serve as concise and practical guidelines for supporting clinicians in the management of patients with CD in Taiwan.
first_indexed 2024-12-13T06:10:57Z
format Article
id doaj.art-8afc459ca45c42c693d73820c8fe84c0
institution Directory Open Access Journal
issn 1598-9100
language English
last_indexed 2024-12-13T06:10:57Z
publishDate 2017-07-01
publisher Korean Association for the Study of Intestinal Diseases
record_format Article
series Intestinal Research
spelling doaj.art-8afc459ca45c42c693d73820c8fe84c02022-12-21T23:57:04ZengKorean Association for the Study of Intestinal DiseasesIntestinal Research1598-91002017-07-0115328531010.5217/ir.2017.15.3.285ir.2017.15.3.285Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel DiseaseShu-Chen Wei0Ting-An Chang1Te-Hsin Chao2Jinn-Shiun Chen3Jen-Wei Chou4Yenn-Hwei Chou5Chiao-Hsiung Chuang6Wen-Hung Hsu7Tien-Yu Huang8Tzu-Chi Hsu9Chun-Chi Lin10Hung-Hsin Lin11Jen-Kou Lin12Wei-Chen Lin13Yen-Hsuan Ni14Ming-Jium Shieh15I-Lun Shih16Chia-Tung Shun17Yuk-Ming Tsang18Cheng-Yi Wang19Horng-Yuan Wang20Meng-Tzu Weng21Deng-Chyang Wu22Wen-Chieh Wu23Hsu-Heng Yen24Jau-Min Wong25Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.Department of Pathology, Taipei City Hospital Renai Branch, Taipei, Taiwan.Division of Colorectal Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.Division of Colorectal Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.Division of Gastroenterology and Hepatology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.Division of General Surgery, Department of Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.Department of Internal Medicine, National Cheng Kung University Hospital, National Cheng Kung University College of Medicine, Tainan, Taiwan.Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Municipal Hsiaokang Hospital, Kaohsiung, Taiwan.Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.Division of Colon and Rectal Surgery, Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan.Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan.Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.Department of Oncology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.Department of Medical Imaging, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.Department of Pathology and Forensic Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.Division of Medical Imaging, Department of Radiology, Far Eastern Memorial Hospital, New Taipei City, Taiwan.Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.Division of Gastroenterology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan.Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.Division of Gastroenterology, Department of Medicine, Taipei City Hospital Renai Branch, Taipei, Taiwan.Division of Gastroenterology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan.Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.Crohn's disease (CD) is a chronic relapsing and remitting inflammatory disease of the gastrointestinal tract. CD is rare in Taiwan and other Asian countries, but its prevalence and incidence have been steadily increasing. A steering committee was established by the Taiwan Society of Inflammatory Bowel Disease to formulate statements on the diagnosis and management of CD taking into account currently available evidence and the expert opinion of the committee. Thorough clinical, endoscopic, and histological assessments are required for accurate diagnosis of CD. Computed tomography and magnetic resonance imaging are complementary to endoscopic evaluation for disease staging and detecting complications. The goals of CD management are to induce and maintain remission, reduce the risk of complications, and improve quality of life. Corticosteroids are the mainstay for inducing re-mission. Immunomodulating and biologic therapies should be used to maintain remission. Patients should be evaluated for hepatitis B virus and tuberculosis infection prior to treatment and receive regular surveillance for cancer. These consensus statements are based on current local evidence with consideration of factors, and could be serve as concise and practical guidelines for supporting clinicians in the management of patients with CD in Taiwan.https://doi.org/10.5217/ir.2017.15.3.285TaiwanCrohn diseaseInflammatory bowel diseasesDisease managementConsensus statements
spellingShingle Shu-Chen Wei
Ting-An Chang
Te-Hsin Chao
Jinn-Shiun Chen
Jen-Wei Chou
Yenn-Hwei Chou
Chiao-Hsiung Chuang
Wen-Hung Hsu
Tien-Yu Huang
Tzu-Chi Hsu
Chun-Chi Lin
Hung-Hsin Lin
Jen-Kou Lin
Wei-Chen Lin
Yen-Hsuan Ni
Ming-Jium Shieh
I-Lun Shih
Chia-Tung Shun
Yuk-Ming Tsang
Cheng-Yi Wang
Horng-Yuan Wang
Meng-Tzu Weng
Deng-Chyang Wu
Wen-Chieh Wu
Hsu-Heng Yen
Jau-Min Wong
Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
Intestinal Research
Taiwan
Crohn disease
Inflammatory bowel diseases
Disease management
Consensus statements
title Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
title_full Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
title_fullStr Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
title_full_unstemmed Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
title_short Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
title_sort management of crohn s disease in taiwan consensus guideline of the taiwan society of inflammatory bowel disease
topic Taiwan
Crohn disease
Inflammatory bowel diseases
Disease management
Consensus statements
url https://doi.org/10.5217/ir.2017.15.3.285
work_keys_str_mv AT shuchenwei managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT tinganchang managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT tehsinchao managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT jinnshiunchen managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT jenweichou managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT yennhweichou managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT chiaohsiungchuang managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT wenhunghsu managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT tienyuhuang managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT tzuchihsu managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT chunchilin managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT hunghsinlin managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT jenkoulin managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT weichenlin managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT yenhsuanni managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT mingjiumshieh managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT ilunshih managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT chiatungshun managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT yukmingtsang managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT chengyiwang managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT horngyuanwang managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT mengtzuweng managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT dengchyangwu managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT wenchiehwu managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT hsuhengyen managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease
AT jauminwong managementofcrohnsdiseaseintaiwanconsensusguidelineofthetaiwansocietyofinflammatoryboweldisease